UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Pinduoduo
PDD
|
+$1.65B |
| 2 |
Accenture
ACN
|
+$1.54B |
| 3 |
Linde
LIN
|
+$1.24B |
| 4 |
Prologis
PLD
|
+$1.08B |
| 5 |
Microsoft
MSFT
|
+$914M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$809M |
| 2 |
Blackrock
BLK
|
+$809M |
| 3 |
Lam Research
LRCX
|
+$735M |
| 4 |
Meta Platforms (Facebook)
META
|
+$563M |
| 5 |
UBS Group
UBS
|
+$411M |
Sector Composition
| 1 | Technology | 33.21% |
| 2 | Financials | 12.03% |
| 3 | Healthcare | 11.96% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Collegium Pharmaceutical
COLL
$1.19B
| $2.29M | ﹤0.01% |
59,326
-9,984
| -14% | -$386K |
|
1952
Enovix
ENVX
$1.99B
| $2.29M | ﹤0.01% |
280,413
-19,283
| -6% | -$158K |
|
1953
Travere Therapeutics
TVTX
$2.43B
| $2.28M | ﹤0.01% |
163,175
-15,574
| -9% | -$218K |
|
1954
QCR Holdings
QCRH
$1.32B
| $2.28M | ﹤0.01% |
30,820
-2,902
| -9% | -$215K |
|
1955
Pennant Group
PNTG
$850M
| $2.28M | ﹤0.01% |
63,865
-3,293
| -5% | -$118K |
|
|
RWT
1956
Redwood Trust
RWT
$801M
| $2.25M | ﹤0.01% |
291,563
+79,094
| +37% | +$611K |
|
1957
Edgewise Therapeutics
EWTX
$1.55B
| $2.25M | ﹤0.01% |
84,294
+4,426
| +6% | +$118K |
|
1958
Par Pacific Holdings
PARR
$1.69B
| $2.25M | ﹤0.01% |
127,732
+8,844
| +7% | +$156K |
|
1959
Kaspi.kz JSC
KSPI
$16.2B
| $2.25M | ﹤0.01% |
21,206
+16,456
| +346% | +$1.74M |
|
1960
Great Lakes Dredge & Dock
GLDD
$815M
| $2.25M | ﹤0.01% |
213,330
+13,203
| +7% | +$139K |
|
1961
Baytex Energy
BTE
$1.83B
| $2.24M | ﹤0.01% |
755,172
-127,893
| -14% | -$380K |
|
1962
US Physical Therapy
USPH
$1.23B
| $2.23M | ﹤0.01% |
26,366
-3,817
| -13% | -$323K |
|
1963
Intercorp Financial Services
IFS
$4.65B
| $2.23M | ﹤0.01% |
85,200
| – | – |
|
1964
Frontline
FRO
$5.02B
| $2.23M | ﹤0.01% |
97,411
-15,298
| -14% | -$350K |
|
1965
TeraWulf
WULF
$4.14B
| $2.22M | ﹤0.01% |
473,415
-68,229
| -13% | -$319K |
|
1966
Core Laboratories
CLB
$577M
| $2.21M | ﹤0.01% |
119,443
+133
| +0.1% | +$2.46K |
|
1967
Rocket Pharmaceuticals
RCKT
$343M
| $2.21M | ﹤0.01% |
119,633
+1,561
| +1% | +$28.8K |
|
1968
Dorian LPG
LPG
$1.35B
| $2.2M | ﹤0.01% |
64,038
-11,566
| -15% | -$398K |
|
|
ARR
1969
Armour Residential REIT
ARR
$1.74B
| $2.2M | ﹤0.01% |
108,029
+32,351
| +43% | +$660K |
|
1970
iShares Russell 2000 ETF
IWM
$66.4B
| $2.2M | ﹤0.01% |
9,970
| – | – |
|
1971
Shoe Carnival
SCVL
$653M
| $2.2M | ﹤0.01% |
50,069
+6,946
| +16% | +$305K |
|
1972
Aurinia Pharmaceuticals
AUPH
$1.61B
| $2.19M | ﹤0.01% |
298,454
-27,428
| -8% | -$201K |
|
|
LGF.B
1973
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $2.18M | ﹤0.01% |
315,525
-13,260
| -4% | -$91.8K |
|
1974
MarineMax
HZO
$545M
| $2.18M | ﹤0.01% |
61,879
+4,548
| +8% | +$160K |
|
1975
FB Financial Corp
FBK
$2.86B
| $2.17M | ﹤0.01% |
46,225
-6,934
| -13% | -$325K |
|